1819 related articles for article (PubMed ID: 25240973)
1. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
[TBL] [Abstract][Full Text] [Related]
3. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.
Radtke JP; Takhar M; Bonekamp D; Kesch C; Erho N; du Plessis M; Buerki C; Ong K; Davicioni E; Hohenfellner M; Hadaschik BA
Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844
[TBL] [Abstract][Full Text] [Related]
5. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
[TBL] [Abstract][Full Text] [Related]
6. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
7. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
[TBL] [Abstract][Full Text] [Related]
8. Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer.
Baco E; Rud E; Ukimura O; Vlatkovic L; Svindland A; Matsugasumi T; Bernhard JC; Rewcastle JC; Eggesbø HB
Urol Oncol; 2014 Nov; 32(8):1300-7. PubMed ID: 25189687
[TBL] [Abstract][Full Text] [Related]
9. Comparing Image-guided targeted Biopsies to Radical Prostatectomy Specimens for Accurate Characterization of the Index Tumor in Prostate Cancer.
Porpiglia F; DE Luca S; Checcucci E; Garrou D; Manfredi M; Mele F; Pecoraro A; Passera R; Bollito E; Fiori C
Anticancer Res; 2018 May; 38(5):3043-3047. PubMed ID: 29715138
[TBL] [Abstract][Full Text] [Related]
10. Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies.
Sheikh N; Wei C; Szewczyk-Bieda M; Campbell A; Memon S; Lang S; Nabi G
World J Urol; 2017 Feb; 35(2):213-220. PubMed ID: 27236302
[TBL] [Abstract][Full Text] [Related]
11. Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen.
Velez E; Fedorov A; Tuncali K; Olubiyi O; Allard CB; Kibel AS; Tempany CM
Abdom Radiol (NY); 2017 Aug; 42(8):2154-2159. PubMed ID: 28293720
[TBL] [Abstract][Full Text] [Related]
12. Gleason Score Determination with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Guided Prostate Biopsies--Are We Gaining in Accuracy?
Lanz C; Cornud F; Beuvon F; Lefèvre A; Legmann P; Zerbib M; Delongchamps NB
J Urol; 2016 Jan; 195(1):88-93. PubMed ID: 26165586
[TBL] [Abstract][Full Text] [Related]
13. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
[TBL] [Abstract][Full Text] [Related]
14. High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.
Steurer S; Rico SD; Simon R; Minner S; Tsourlakis MC; Krech T; Koop C; Graefen M; Heinzer H; Adam M; Huland H; Schlomm T; Sauter G; Lumiani A
BJU Int; 2017 Sep; 120(3):365-376. PubMed ID: 28295933
[TBL] [Abstract][Full Text] [Related]
15. The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy.
Arsov C; Becker N; Rabenalt R; Hiester A; Quentin M; Dietzel F; Antoch G; Gabbert HE; Albers P; Schimmöller L
J Cancer Res Clin Oncol; 2015 Nov; 141(11):2061-8. PubMed ID: 26013424
[TBL] [Abstract][Full Text] [Related]
16. Pathological Concordance between Prostate Biopsies and Radical Prostatectomy Using Transperineal Sector Mapping Biopsies: Validation and Comparison with Transrectal Biopsies.
Marra G; Eldred-Evans D; Challacombe B; Van Hemelrijck M; Polson A; Pomplun S; Foster CS; Brown C; Cahill D; Gontero P; Popert R; Muir G
Urol Int; 2017; 99(2):168-176. PubMed ID: 28768264
[TBL] [Abstract][Full Text] [Related]
17. Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies.
Ukimura O; Marien A; Palmer S; Villers A; Aron M; de Castro Abreu AL; Leslie S; Shoji S; Matsugasumi T; Gross M; Dasgupta P; Gill IS
World J Urol; 2015 Nov; 33(11):1669-76. PubMed ID: 25656687
[TBL] [Abstract][Full Text] [Related]
18. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.
Washington SL; Bonham M; Whitson JM; Cowan JE; Carroll PR
BJU Int; 2012 Jul; 110(1):50-5. PubMed ID: 22077660
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging‑directed biopsy improves the prediction of prostate cancer aggressiveness compared with a 12‑core transrectal ultrasound‑guided prostate biopsy.
Zhang J; Xiu J; Dong Y; Wang M; Han X; Qin Y; Huang Z; Cai S; Yuan X; Liu Q
Mol Med Rep; 2014 May; 9(5):1989-97. PubMed ID: 24584266
[TBL] [Abstract][Full Text] [Related]
20. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
